Compare Occidental Petroleum Corporation (OXY) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Occidental Petroleum Corporation vs Repligen Corporation Common Stock — how do they compare? Occidental Petroleum Corporation trades at $61.82 (market cap $61.63B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Occidental Petroleum Corporation is far larger — about 5.5× Repligen Corporation Common Stock's market cap, and Occidental Petroleum Corporation pays a 1.82% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Occidental Petroleum Corporation for 92 Days and Repligen Corporation Common Stock for 0 Days on average.
| OXY | RGEN | |
|---|---|---|
Market Cap | $61.63B | $11.14B |
Volume | 9,180,422 | 1,259,263 |
Sector | Energy | Health |
52-Week High | $66.24 | $194.57 |
52-Week Low | $38.92 | $102.87 |
Typical Hold Time | 92 Days | 0 Days |
Enterprise Value | $80.39B | $11.02B |
Dividend Yield | 1.82% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Occidental Petroleum (OXY) trades at $61.65, up 0.85% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $70.92. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Financials show strong profitability with a 30.32% net income margin and robust cash flow, though revenue has declined from 2022 peaks. Recent news highlights focus on dividend reliability and Goldman Sachs' upgrade citing cash flow targets and debt reduction.
OXY presents a favorable outlook with earnings momentum, attractive valuation multiples, and analyst support, but faces risks from oil price volatility and competitive pressures. The stock's upside potential hinges on execution of debt reduction and sustained operational efficiency amid energy market fluctuations.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
